Home › Heart Attack › Texas › Austin
Heart Attack clinical trials in Austin, TX
3 studies for Heart Attack are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Cussimanio Research Group LLC, Austin
- Research Management, Inc., Austin
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Texas Diabetes and Endocrinology, Austin
- Ima Clinical Research, Austin
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RecruitingObservational studyHealthy volunteers welcome
- Texas Cardiac Arrhythmia Research Foundation, Austin
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- New York City, NY6 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Knoxville, TN3 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Greensboro, NC3 studies
- Durham, NC3 studies
- Los Angeles, CA3 studies
- Nashville, TN3 studies
- Detroit, MI3 studies
Other studies in Austin
- Non-Small Cell Lung Cancer29 studies
- Cancer (all types)22 studies
- Obesity22 studies
- Overweight19 studies
- Metastatic Cancer18 studies
- Colorectal Cancer17 studies
- Ovarian Cancer17 studies
- Heart Failure17 studies
- Endometrial Cancer15 studies
- Breast Cancer15 studies
- Type 2 Diabetes14 studies
- Prostate Cancer14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.